Revolution Medicines Net Common Equity Issued/Repurchased 2018-2025 | RVMD
Revolution Medicines net common equity issued/repurchased for the twelve months ending March 31, 2025 was $1.054B, a 47.64% decline year-over-year.
- Revolution Medicines annual net common equity issued/repurchased for 2024 was $0.959B, a 22.23% decline from 2023.
- Revolution Medicines annual net common equity issued/repurchased for 2023 was $1.233B, a 309.18% increase from 2022.
- Revolution Medicines annual net common equity issued/repurchased for 2022 was $0.301B, a 2.3% increase from 2021.